REVBW
Revelation Biosciences, Inc.
Revelation Biosciences, Inc. (REVBW) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 50.5, with 0/3 trend checks passing.
REVBW with MA50 and MA200
Key levels & signals
Revelation Biosciences, Inc. (REVBW) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $0.01, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 7.9% and below the 200-day moving average by 8.0%.
REVBW currently has an RSI reading of 50.5, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.
For traders reviewing REVBW next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.
About Revelation Biosciences, Inc.
Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering immunology-based therapies and diagnostic tools aimed at preventing and treating a range of illnesses. Their flagship therapeutic, REVTx-99, is an intranasal immunomodulator designed to both prevent and treat a broad spectrum of respiratory viral infections, including SARS-CoV-2 (and its variants), influenza A and B, parainfluenza, rhinovirus, and RSV. Furthermore, its potential extends to addressing allergic rhinitis and chronic nasal congestion. The company's pipeline also includes REVTx-200, an intranasal immunomodulator intended as an adjunct to enhance the efficacy of intramuscular vaccinations, thereby boosting immunity. Additionally, they are developing REVDx-501, a rapid diagnostic test designed for convenient home use to detect respiratory viral infections. Established in 2019, the company is headquartered in New York, New York.
Learn the indicators behind this page
More stock opportunities
Common questions about REVBW
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.